2019-06-28T11:49:34-07:00 2018-08-31 990 2017-09-01 581698648 THE TASK FORCE FOR GLOBAL HEALTH INC TASK 4045921430 325 Swanton Way Decatur GA 300303001 William Nichols Chief Operating Officer 4045921430 2019-04-18 38.142.128.234 2017 2019-02-21 02:37:17Z William Nichols 325 Swanton Way Decatur GA 30030 46208717 0 X www.taskforce.org X 1986 GA The mission of The Task Force for Global Health is to solve large-scale health problems affecting vulnerable populations around the world and to build sustainable systems that protect and promote health. 9 8 122 7 -99832 0 85304040 45383048 0 0 89763 201199 317413 -322185 85711216 45262062 5771652 5399935 0 0 15915752 18013111 0 0 129715 40655354 38360394 62342758 61773440 23368458 -16511378 80897001 61988899 13934675 11537951 66962326 50450948 The mission of The Task Force for Global Health is to solve large-scale health problems affecting vulnerable populations around the world and to build sustainable systems that protect and promote health. 0 0 24593998 195741 29994000 The Health Systems Strengthening Area includes Public Health Informatics Institute(PHII);Training Programs in Epidemiology and Public Health(TEPHINET); African Health Workforce Project(AWP) and MedSurplus Alliance(MSA). TEPHINET accomplished the following during the 2018 Fiscal Year: * The TEPHINET Global Accrediting Body accredited five field epidemiology training programs (FETPs) as a result of TEPHINET's second cycle of the accreditation of FETPs. The programs accredited in that cycle are based in Brazil, Cameroon, Kenya, Philippines, and Zimbabwe. * TEPHINET held accreditation workshops for the leadership of regional FETPs at regional scientific conferences in Amman, Jordan and Cartagena, Colombia. * TEPHINET conducted a complete overhaul to improve the content and usability of its accreditation-related documentation, including application forms and reference documents, at the recommendation of past participants in the accreditation process. * TEPHINET hosted the 2018 TEPHINET Program Directors Meeting in Johannesburg, South Africa, convening leadership from approximately 50 of our member FETPs and partner regional FETP networks. The meeting was used as a forum to get feedback on several strategic initiatives TEPHINET is undertaking, including: The improvement of the quality of TEPHINET scientific conferences; the development of an FETP alumni network to facilitate workforce mobilization during health emergencies; the development of a new continuous learning strategy to support the needs of TEPHINET's FETP network; and many more. * TEPHINET grew its newly launched global FETP alumni online community, TEPHIConnect, to more than 1,000 members. * TEPHINET and CDC co-hosted the 2018 FETP International Nights in Atlanta, Georgia, USA in April 2018. This event gives FETP trainees and graduates from around the world the opportunity to present their work at the annual Epidemic Intelligence Service (EIS) Conference. A total of twenty-one poster presenters and six oral presenters were accepted from a pool of more than 300 authors of scientific abstracts related to field epidemiology. * TEPHINET, the National Institute of Health of Colombia, and the University El Bosque in Bogota co-hosted a scientific meeting on melioidosis in the Americas in April 2018. * TEPHINET and the National Institute of Health of Colombia co-hosted the 10th TEPHINET Regional Scientific Conference of the Americas in Cartagena, Colombia, in May 2018. The event drew roughly 300 participants from across the Americas and featured 52 oral presentations and 54 poster presentations selected from a pool of more than 300 abstracts. The conference also featured seven pre-conference workshops, seven plenary sessions, and a symposium for FETP leadership from the region on lessons learned during FETP-Frontline implementation as a strategy to combat Zika and vector-borne diseases. * Participants from the TEPHINET Secretariat and network of programs participated in a meeting held by the Task Force for Global Health at the Rockefeller Foundation Bellagio Center in June 2018 to develop a roadmap for building global epidemiological capacity through field epidemiology training programs. * With support from USAID and Tulane University, TEPHINET field teams conducted the first KAP (knowledge, attitudes and practices) study on Zika in El Salvador, Guatemala and Honduras. * TEPHINET launched e-learning modules on public health laboratory core competencies, cancer prevention and control, and entomology in public health. * TEPHINET staff gave three poster presentations at the International Conference on Emerging Infectious Diseases held in Atlanta, Georgia in August 2018. PHII provided direct services to the U.S. public health system through a cooperative agreement with the CDC and funding from the de Beaumont and Robert Wood Johnson foundations. This funding supported PHII and its partners in efforts to increase the capacity of public health informaticians and other public health leaders and practitioners to improve the collection, management and use of information and information technology for protecting and improving health and reducing disparities. Key activities included in 2018 included providing technical assistance and online tools to state and local health departments in linking to private healthcare electronic records systems for the purpose of electronically reporting disease cases; in providing training to public health professionals in essential informatics competencies; and in assessing non-communicable and injury epidemiology capacity in state and/or local health departments in informatics, data and methods. The funding also supported the continuing development and use of a workforce deployment tool that assists African countries in allocating health workers to high-need areas in order to strengthen HIV treatment and prevention. Additionally, PHII is a partner on a collaborative Gates Foundation-funded project that is collecting data to reduce childhood mortality across the globe; this project is working on mortality surveillance activities at sites in Asia and Africa. Finally, this year, Emory's Department of Human Genetics and the Metabolic Nutrition Program continued to fund PHII in designing and building a health information system that streamlines multiple sources of information about patients with metabolic disorders. The new system will enable providers to manage their patients' overall healthcare needs in a more efficient manner, including specialized food and formulas prescribed for patients. AWP - The US President's Emergency Plan for AIDS Relief (PEPFAR) has set a new vision of an AIDS-free generation based on a strong evidence base particularly for antiretroviral treatment (ART) as prevention of adult transmission, prevention of mother-child transmission, and voluntary medical male circumcision. All three of the major prevention strategies towards an AIDS-free generation rely on an adequate and well trained health workforce. Like many Sub-Saharan African countries, Kenya faces shortages of health professionals, poor skill mix, and mal-distribution of workers. Over the past 14 years, the African Health Workforce Project has worked in collaboration with 8 of Kenya's health professional regulatory agencies to establish regulatory human resource information systems (rHRIS) that provide data on the expansion of the health workforce, location and number of health professionals, skill mix, and other data for program planning. These data can be analyzed to evaluate transparency, accountability, and current geographical focus of the distribution and skills of the health workforce compared with the need for professionals to improve HIV prevention, care and treatment programs. Having completed phase I-establishing rHRIS in all 8 of Kenya's regulatory agencies-the project began phase II in October 2017, which has the following objectives and accomplishments in year 1: 1) Greater dissemination of data on health professionals at the national and county levels especially through use of technology. The project held sensitization, data assessment and data analytic training workshops for 10 of the targeted 20 counties with high HIV burden. 2) Greater transparency in the distribution of health professionals especially in HIV high burden areas and hard-to-reach areas. Worked with researchers at CDC to develop a survey of PEPFAR-funded HIV clinics to provide information on their current workforce. 3) Capacity building for local/county health managers and information officers to utilize these data to ensure more appropriate distribution and deployment of health professionals and health program planning. Held data analytic training workshops for 10 of the targeted 20 counties. 4) Development of sustainable data analytic resources for national and county health officials and managers. Provided training to 10 counties on abstract writing and scientific reporting. 5) Provision of data and analyses needed at the national and county level in support of evidence driven policy development. Developed first draft of data dashboards that will be available to national and county health officials. 6) Realization of interoperability of health data systems at national and county level to provide a more complete picture of the health workforce. Completed interoperability for the regulatory and deployment HR databases that is now available in the 10 counties. MSA - A well-functioning health system ensures access to essential medical products, vaccines, and devices. By eliminating medical supply stock outs and creating access to quality supplies and working medical equipment, we can remove a significant barrier to reducing patient morbidity and mortality in low-income settings. The MedSurplus Alliance is a cross-sector alliance that works collaboratively to improve access to quality donated medical products, through standards and accreditation, capacity-building, managemen 20399016 4995909 11159180 The Neglected Tropical Disease Area includes: CWW (Children Without Worms); ITI (The International Trachoma Initiative); NTD-SC (the Neglected Tropical Disease-Support Center); MDP (The Mectizan Donation Program) and LEP(Global Partnership for Zero Leprosy). The International Trachoma Initiative (ITI) has established a unique competitive advantage within the global trachoma community based on its singular focus on trachoma, its credibility as a neutral convener and trusted ally, its flexibility and ability to lead initiatives in support of scale-up, and its role as the sole steward of Pfizer, Inc.'s Zithromax(R) drug donation. ITI fulfills three value-adding roles that contribute to the implementation of the WHO-endorsed SAFE strategy (Surgery, Antibiotic treatment, Facial cleanliness, Environmental improvement , namely: 1) stewardship of the Zithromax(R) drug donation; 2) program delivery strengthening, through operational research, knowledge sharing, capacity building and technical backstopping; and 3) partnership development, through support to the International Coalition for Trachoma Control (ICTC), spearheading WASH/NTD engagement, and mobilizing resources for trachoma. In 2018, ITI celebrated 20 years of working for a world free from trachoma and organized just-in-time shipments of over 101.5 million doses of Zithromax(R) to 17 countries, bringing the cumulative total of doses donated since its inception in 1998 to over 810 million doses. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision making on where antibiotic treatments are needed and where they can be stopped. ITI's commitment to strong stewardship of the antibiotic donation from Pfizer, coupled with its solid data management and transparent communications, have contributed to remarkable achievements by the global trachoma community in reducing the population at risk of blindness from this preventable disease from an estimated 1.2 billion people in 2000 to 142 million in 2018. With just two years left until the World Health Organization's global trachoma elimination goal, ITI will continue to enhance its support, improve its effectiveness, and increase its efficiencies to maximize impact. CWW - In FY2018, with funding from Johnson & Johnson and GlaxoSmithKline, Children Without Worms (CWW), CWW successfully designed and implemented model soil-transmitted helminthiasis (STH) control programming. As the STH Coalition secretariat, CWW convened numerous well-attended forums to share best practices with the STH community, including on scaling-up preventive chemotherapy to women of reproductive age. An annual STH Coalition Action Group meeting shared Coalition-endorsed tools including the Policy Assessment Tool, which helps national programs to assess and address STH-related policy gaps. Additionally, CWW and the Coalition helped develop the London Declaration Scorecard, which is used to monitor the global STH campaign. In FY2018, using a CWW-developed survey methodology (ICSPM), CWW and the Ministry of Health & Family Welfare - Bangladesh conducted three district-level population-based program monitoring surveys. The surveys measured prevalence and coverage of preventive chemotherapy and water and sanitation. The three 2018 surveys follow surveys conducted in 2017. Collectively, the surveys address key programmatic gaps including the addressing areas of continued high STH prevalence. Additionally, the Ministry of Health - Sierra Leone requested and received support for implementing ICSPM surveys in 2018. With initiatives like these led by CWW, other national STH control programs are increasingly accepting the use of parasitologic monitoring for data-driven decisions that are essential to success. NTD-SC Funded principally by the Bill & Melinda Gates Foundation, the U.S. Agency for International Development and the Department for International Development (UK AID), the NTD-SC aims to optimize Operational Research (OR) to eliminate neglected tropical diseases which threaten the lives and well-being of more than one billion of people in some of the world's poorest communities. As of 2018, the NTD-SC manages a portfolio of more than 180 OR projects spanning 60 countries and targeting all five neglected tropical diseases amenable to preventive chemotherapy: lymphatic filariasis, onchocerciasis, STH, schistosomiasis and trachoma. Some of these OR study products have resulted into program recommendations which the World Health Organization (WHO) has endorsed and adopted into WHO policy while others are clinical trials which may result in new therapies for NTD diseases. In addition, the NTD-SC serves as the Secretariat for the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) yearly meeting. This meeting brings together a growing group of researchers and country program implementers working to foster important collaborations to address the challenges faced by NTD programs which prevent the shared goal of eliminating these infections. The 2-day event convened nearly four hundred individuals from more than 40 countries, translating ideas into future OR projects for 2019. MDP - In 2018, 300+ million treatments were approved for onchocerciasis control and elimination in 24 African countries and in Brazil and Venezuela. Program downscaling Onchocerciasis has been eliminated in four of the six endemic countries (Brazil, Colombia, Ecuador, Guatemala, Mexico, and Venezuela) in the Americas. Only the Yanomami Indian region overlapping Brazil and Venezuela remains - though this is a challenge given the political climate and nomadic lifestyle of the target population. In Uganda, one additional focus stopped treatment in 2018 in Uganda where 16 out of the 17 endemic foci have completed or are under post-treatment surveillance for onchocerciasis. Plateau and Nasarawa states in Nigeria stopped treatment for onchocerciasis, which is a remarkable achievement in one of the most heavily endemic countries. In Ethiopia, treatment was stopped in Metema Focus, Amhara State, which shares a border with Sudan. National onchocerciasis Elimination Committees (NOECs) are currently established in 17 out of the 29 endemic countries. The Mectizan Donation Program facilitated cross-country participation in NOEC meetings by supporting travel for NOEC members to attend meetings in other countries. Further, NOEC chairs from four countries in Africa participated in the Fall Mectizan Expert Committee Meeting. Lymphatic Filariasis By the end of 2018, 257.7 million treatments of Mectizan and albendazole were approved for the elimination lymphatic filariasis (LF) in 23 African countries. Since the inception of the program in 2000, treatment for LF has stopped in 468 implementation units. Downscaling continues in a number of African countries where 118 million individuals no longer need treatment with Mectizan and albendazole in Benin, Burkina Faso, Cameroon, Ghana, Malawi, Mali, Niger, Nigeria, Tanzania, Togo, Uganda and Yemen. Twenty million of these will continue to receive Mectizan treatment for onchocerciasis. The donation of albendazole and Mectizan was expanded in 2018 to include countries outside of Africa to accelerate elimination of LF. Kenya, India, Samoa, American Samoa and Tuvalu began implementing the new World Health Organization's triple therapy strategy, which includes Mectizan and albendazole. The Global Partnership Zero Leprosy Program accomplished the following in 2018: 1. Established and fostered partnership * Facilitated the creation of a new global network with more than 400 organizations and individuals as members. Items collaboratively developed include: GPZL charter, long-term GPZL Framework for Action, 2018 and 2019 Strategic Outlines and work plans, values statement, partnership and advocacy plan and policy documents. * Ensured systematic, strategic and transparent discussion and negotiation to foster the efficient functioning of the GPZL Leadership Team including monthly teleconferences and two in-person meetings (Colchester and Brussels) for strategic planning. Meeting notes are available on the website. * Fostered a strong and engaged scientific and policy network that actively supports the Partnership's work through workshops at the NNN, WHO leprosy program directors' meetings and the COR-NTD meeting. GPZL members participated in an International Task Force for Disease Eradication meeting. * Implemented a communications strategy to support network and fundraising goals including unified messaging, a website, monthly newsletter, social media, brochure, logo and other materials. * Executed an organizational development strategy that increased membership from the original 7 founding organizations to over 400+ organizations and individual members. Conducted mapping of potential Leaders 9039117 208285 3257441 In fiscal year 2018, The Center for Vaccine Equity made substantial progress in existing program areas, and expanded its role in current programs and added new program areas. Polio Eradication Support In support of Global Polio Eradication (GPEI), the Center successfully concluded a 2-year effort assisting 16 priority countries with planning for the transition of polio related financial and technical assets to country ministries. The Center's work in support of Polio Emergency Operations Management continues to grow with funding provided to establish an emergency outbreak response team. The team will support the Centers for Disease Control and Prevention (CDC) and other GPEI partners in high-priority surveillance and outbreak response activities around the globe. Serving as the secretariat for the US Polio National Certification Committee, CVE convened a meeting of the committee and submitted a report on the status of US containment to the Regional Certification Committee. The Polio Antiviral Initiative (PAI), the Center's antiviral development program, began a Phase 1 clinical study of the antiviral V-7404, one of two antiviral compounds with different mechanisms of action being developed in the program. The other antiviral, pocapavir, has been administered on a compassionate use basis to treat immune deficient individuals who are excreting poliovirus for prolonged periods. Influenza In its fifth year of operation, the Partnership for Influenza Vaccine Introduction (PIVI) extended its impact to its 14th country partner receiving vaccine, financial and/or technical support. The Partnership donated ~800,000 doses of influenza vaccine in fiscal year 2018 and provided ~$200,000 in direct financial support to national influenza programs for capacity building activities. The project team is completing work on a dossier for use by National Immunization Technical Advisory Groups that provides guidance on the burden of disease and appropriate use of influenza vaccines. The Global Funders Consortium for Universal Influenza Vaccine Development initiated plans to establish a platform to track and provide accurate information about next generation influenza vaccines. The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota has been contracted to collaborate with the Unifluvac Working Group in compiling and curating an open-access database of universal influenza vaccine candidates and technologies currently in development. Hepatitis With the support of the CDC, The Center began development of a coalition to accelerate progress toward the elimination of viral hepatitis, the leading cause of liver cancer and death for millions of people around the world. The Coalition for Global Hepatitis Elimination is bringing together public and private partners to forge consensus on elimination goals, share knowledge and experience among implementing programs, provide technical assistance, generate new knowledge through operational research, and advocate for viral hepatitis elimination. The coalition will operate as a technical hub modeled after other Task Force for Global Health disease elimination programs. Scientific Conference Management In 2018, The Center supported CDC as a co-conference organizer in managing the May National Immunization Conference, and the August International Conference on Emerging Infectious Diseases. The conferences were attended by 3,000 public health professionals and research scientists. 0 0 0 54032131 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 1 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 155 0 0 122 1 1 1 1 CO ET GT 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 GA X X Daniel N Martins 4046875620 325 Swanton Way Decatur GA 300303001 Teri Plummer McClure Board Chair 1 0 X 0 0 0 James W Curran Board Member 1 0 X 0 0 0 Paula Lawton Bevington Board Member 1 0 X 0 0 0 Mary Ann Peters Board Member 1 0 X 0 0 0 Charles H McTier Board Member 1 0 X 0 0 0 David A Ross President and CEO 39 1 X X 342303 0 0 William P Nichols Chief Operating Officer 39 1 X 234914 0 0 Heather Brooks Director of Organizational Effectiveness 39 1 X 159179 0 0 Mark McKinlay Program Director 39 1 X 235466 0 0 Daniel Martins Chief Financial Officer 39 1 X 137328 0 0 Eric Ottesen Program Director 40 0 X 253117 0 0 Dionisio Jose Herrera Guibert Program Director 40 0 X 217934 0 0 Paul Emerson Program Director 40 0 X 211142 0 0 Vivian Singleton Program Director 40 0 X 220697 0 0 Patrick O'Carroll Program Sector Head 40 0 X 249284 0 0 Poul Olson Director of Communications 40 1 X 117754 0 0 Patrick Lammie Sr. Public Health Scientist 40 0 X 197950 0 0 Martha Rogers Program Director 40 0 X 237498 0 0 David G Addis Program Director 40 1 X 184024 0 0 Yao Sodahlon Program Director 40 0 X 202109 0 0 Ellen Wild Director of Business Strategy 40 0 X 155573 0 0 Timothy Morris Chief Information Officer - PHII/CHAMPS 40 0 X 194492 0 0 Rubina Imtiaz Program Director 40 0 X 217254 0 0 Mark Rosenberg President and CEO 39 1 X 162999 0 0 3931017 0 0 42 1 1 0 Freese Johnson Construction Company 1355 Terrell Mill Rd Bldg 1470 Suite 100 Marietta GA 30067 Building Construction Company 5112396 ViroDefense Inc 5425 Wisconsin Avenue Suite 600 Chevy Chase MD 20815 Antiviral research and development consulting 1500000 Deloitte Consulting LLP 4022 Sells Drive Hermitage TN 37076 Consulting services 832688 HLN Consulting 72810 Hedgehog St Palm Desert CA 92260 Informatic services 595875 Office Creations Inc 5250 Brook Hollow Parkway Norcross GA 30071 Manufactures office furniture 439874 1 0 0 29883 0 27267850 18085315 0 45383048 0 201199 201199 0 0 0 0 0 0 0 0 0 0 624470 0 846823 0 -222353 0 -222353 -222353 0 0 0 0 0 0 0 0 0 0 0 0 0 29883 99832 -99832 -99832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 45262062 -21154 -99832 0 0 0 0 0 5399935 5399935 0 0 4827193 2822042 1962178 42973 0 0 0 0 10173567 8175153 1998414 0 824240 662333 161907 0 1491275 1198341 292934 0 696836 532022 164814 0 15270277 14741153 473786 55338 63060 14125 48935 0 15555 5041 10514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 138765 130405 1313 7047 2106376 1929649 175345 1382 761544 413461 348083 0 0 0 0 0 508647 246673 261974 0 3878842 3675235 203607 0 0 0 0 0 3311400 3083394 205190 22816 202674 0 202674 0 0 0 0 0 837332 0 837332 0 186773 36843 149930 0 Bank Charges 130809 128755 1895 159 Dues and Subscriptions 76805 29078 47727 0 Miscellaneous 182855 154371 28484 0 Other Direct Program Expense 10688680 10654122 34558 0 0 0 0 0 61773440 54032131 7611594 129715 0 55018822 31964714 6153650 2441658 0 0 0 0 0 0 0 0 0 216765 847998 30525409 3790880 19507764 26734529 0 0 0 0 0 0 0 0 0 0 80897001 61988899 2072587 2472336 0 0 0 412321 6825000 6475000 0 0 0 0 0 0 0 0 5037088 2178294 13934675 11537951 X 25472002 26910932 41490324 23540016 0 0 66962326 50450948 80897001 61988899 -16511378 0 0 0 0 0 X 0 1 X 1 1 1 X 29925159 35776510 42374053 68115208 36813330 213004260 0 0 0 0 0 0 0 0 0 0 0 0 29925159 35776510 42374053 68115208 36813330 213004260 213004260 3966 4472 8370 89763 825669 932240 0 0 0 0 0 0 0 0 0 0 0 0 213936500 0.99564 0.79618 X 2135100 0 2135100 25199867 0 2398563 22801304 0 0 0 0 3069777 0 1271654 1798123 120665 0 120663 2 26734529 0 Payroll Liabilities 1486209 Accrued Absences 316861 Other Accrued Liabilities 375224 2178294 X 45262062 0 0 0 0 0 45262062 0 0 0 45262062 61773440 0 0 0 0 0 61773440 0 0 0 61773440 Schedule D, Part X, Line 2 During December 2017, the President of the United States of America signed into law the Tax Cuts and Jobs Act. Under this Act, maximum corporate tax rates were reduced from 35% to a flat rate of 21%. The Organization's tax liability for any potential unrelated business income should not be significant. There are other changes to the tax law that may affect the Organization, but the magnitude of such changes has not been determined. 1 Central America and the Caribbean 0 0 Program Services Operational research to support the control and elimination of five neglected tropical diseases. 8267 East Asia and the Pacific 0 0 Program Services Operational research to support the control and elimination of five neglected tropical diseases and National Immunization Program support to countries. 823975 Europe (including Iceland and Greenland) 0 0 Program Services Expansion of birth defects surveillance activities via trainings and virtual platform development, development of a technical dossier on influenza immunization program and support for trachoma program. 711349 South Asia 0 0 Program Services Operational research to support the control and elimination of five neglected tropical diseases. 533378 Sub-Saharan Africa 2 12 Program Services To support the control and elimination of Trachoma and Lymphatic filariasis diseases. 3262391 Russia and the newly independent States 0 0 Program Services Support for health care work training related to influenza and influenza surveillance. 60575 2 12 5399935 Central America and the Caribbean Program support in areas of public health. 8267 Wire transfer 0 N/A N/A East Asia and the Pacific Program support in areas of public health. 823975 Wire transfer 0 N/A N/A South Asia Operational research in areas of five neglected tropical diseases 533378 Wire transfer 0 N/A N/A Sub-Saharan Africa Program support in areas of public health. 3262391 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) Program support in areas of public health. 711349 Wire transfer 0 N/A N/A Russia and the newly independent States Program support in areas of public health 60575 Wire transfer 0 N/A N/A 57 3 0 0 0 0 0 0 Schedule F, Part I, Line 2 A contract is executed with all the required deliverables and budget. Based on work performance, an agreed percentage of the grant is paid to the recipient after receiving an invoice and a narrative report. Occasionally, there are visits to the countries for feedback and to assess the impact of the project. Budget over-runs have to be explained before a contract amendment, if necessary, is made. Capital Campaign 29883 0 29883 0 0 0 0 0 129715 0 0 29883 0 29883 0 0 0 0 0 129715 129715 -99832 X X 0 0 0 0 0 0 0 0 0 Teri Plummer McClure Board Chair 0 0 0 0 0 0 0 0 0 0 0 0 0 0 James W Curran Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Paula Lawton Bevington Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Mary Ann Peters Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Charles H McTier Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 David A Ross President and CEO 342303 0 0 0 0 0 23025 0 24817 0 390145 0 0 0 William P Nichols Chief Operating Officer 234914 0 0 0 0 0 21142 0 1055 0 257111 0 0 0 Heather Brooks Director of Organizational Effectiveness 159004 0 0 0 175 0 14622 0 23467 0 197268 0 0 0 Mark McKinlay Program Director 235391 0 0 0 75 0 21602 0 24555 0 281623 0 0 0 Daniel Martins Chief Financial Officer 130100 0 5600 0 1628 0 12287 0 39036 0 188651 0 0 0 Eric Ottesen Program Director 253067 0 0 0 50 0 18982 0 1299 0 273398 0 0 0 Martha Rogers Program Director 237498 0 0 0 0 0 20686 0 1161 0 259345 0 0 0 David G Addis Program Director 184024 0 0 0 0 0 16960 0 22171 0 223155 0 0 0 Dionisio Jose Herrera Guibert Program Director 217934 0 0 0 0 0 19614 0 35059 0 272607 0 0 0 Paul Emerson Program Director 211142 0 0 0 0 0 19409 0 24451 0 255002 0 0 0 Yao Sodahlon Program Director 202109 0 0 0 0 0 18728 0 34438 0 255275 0 0 0 Ellen Wild Director of Business Strategy 155573 0 0 0 0 0 12903 0 753 0 169229 0 0 0 Vivian Singleton Program Director 194180 0 0 0 26517 0 23618 0 15746 0 260061 0 0 0 Timothy Morris Chief Information Officer - PHII/CHAMPS 194492 0 0 0 0 0 17236 0 34505 0 246233 0 0 0 Patrick O'Carroll Program Sector Head 249284 0 0 0 0 0 3843 0 486 0 253613 0 0 0 Rubina Imtiaz Program Director 216704 0 0 0 550 0 19566 0 14131 0 250951 0 0 0 Poul Olson Director of Communications 117754 0 0 0 0 0 10750 0 13387 0 141891 0 0 0 Patrick Lammie Sr. Public Health Scientist 197950 0 0 0 0 0 17815 0 48 0 215813 0 0 0 Mark Rosenberg President and CEO 0 0 162999 0 0 0 0 0 0 0 162999 0 0 0 A Development Authority of DeKalb County 581500666 000000000 2016-12-15 7000000 Finance the purchase of a building 0 0 0 A 525000 0 7000000 0 107991 0 0 0 0 7000000 0 0 2018 0 0 1 1 A 0 0 0 0 0 0 0 1 0 0 A 0 0 0 0 1 0 0 0 0 A 0 Form 990, Part VI, Section B, Line 11b Once the Return is prepared by the CFO, it is made available to all board members for comments,clarifications and corrections. After the board's review, the Return is finalized and filed with the IRS. Form 990, Part VI, Section B, Line 12c Board members, officers, and all employees are required to annually sign a declaration that they have read, and have complied with, the Conflict of Interest Policy. Any suspected or reported violations of the policy are to be referred to the Chief Operating Officer who would follow-up and investigate the matter. Form 990, Part VI, Section B, Line 15 The Task Force for Global Health, Inc. is an affiliate of Emory University and as such, all its employees are in fact Emory employees. For both the President and Chief Operating Officer, Emory includes these positions in its annual market review of compensated professionals in these categories. In addition, performance is measured against SMART goals. Furthermore, the board reviews performance including a 360 feedback loop finalizing the President's performance. Form 990, Part VI, Section C, Line 19 Three years of audited financial statements and 990 Tax Returns are posted on the organization's website together with the Conflict of Interest policy and governing documents - Bylaws